The AEPCC Clinical Trials and Translation Network (CTTN) Establishment Committee has reviewed 10 clinical trials since its inception in August 2021.
Of those, one trial is now fully endorsed and funded and three others have been pre-endorsed and are waiting on funding confirmation before we can determine how AEPCC might be able to support them and meet their specific needs.
But the CTTN isn’t just about endorsing existing trials. It’s also designed to play a pivotal role in collaboratively driving the early psychosis research agenda by understanding what people like you want to explore, and shaping new clinical trials around those key themes.
This is why we’re collecting insights from the early psychosis community through our research prioritisation survey.
If you haven’t already completed the survey, we’d love to hear from you if you’re:
- a member of the early psychosis lived experience community;
- a researcher in this field;
- a clinician providing care to young people experiencing early psychosis;
- or connected in some other way.
We’re passionate about making meaningful change in this space and have received some great feedback to date, but are keen to hear from as many voices as possible.
The survey is still open; we’d be really grateful if you could take a few minutes out of your day to have your say, and also to share with your network.
You can also now register for an interactive online workshop on 19 October, when we’ll take a deep dive into the survey results together.
